National Comprehensive Cancer Network



About NCCN

Myeloid Growth Factors Panel - Disclosures as of 12/21/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

James O. Armitage, MD

None

Genentech, Inc.;
GlaxoSmithKline;
Seattle Genetics;
Spectrum;
Ziopharm;
Roche Laboratories, Inc.

None

Tersaro Bio, Inc.;
Tesaro Bio, Inc.

11/4/2014

Pamela Sue Becker, MD, PhD

Amgen Inc.;
Bristol-Myers Squibb Company;
Celgene Corporation;
Eli Lilly and Company;
Millennium Pharmaceuticals, Inc.;
Glycomimetics;
Igenica;
JW Pharmaceuticals;
sanofi-aventis U.S.

Caremark;
McKesson;
Pfizer Inc.

None

None

11/3/2014

Douglas W. Blayney, MD

Bristol-Myers Squibb Company;
Michigan Oncology Quality Consortium;
Phyhsician Resource Managment

AstraZeneca Pharmaceuticals LP;
Genentech, Inc.;
McLaren Health Systems;
National Oncology Consultants;
Oregon Health Sciences University/Legacy Collaboration;
Physician Resource Management;
Pfizer Inc.;
UnitedHealthcare

Abbott Laboratories;
Amgen Inc.;
Bristol-Myers Squibb Company;
Covidien AG;
Johnson & Johnson;
Express Scrips;
Mallinkridt;
United HealthCare

None

11/21/2014

Jennifer Burns

None

None

None

None

9/24/2014

Spero R. Cataland, MD

None

Alexion Pharmaceuticals, Inc.

None

None

10/29/2014

Jeffrey Crawford, MD

Amgen Inc.;
AstraZeneca Pharmaceuticals LP;
Celgene Corporation;
MedImmune Inc.;
GTx;
Merrimack;
Roche Laboratories, Inc.;
sanofi-aventis U.S.

Bayer HealthCare;
Boehringer Ingelheim GmbH;
Eli Lilly and Company;
Gilead;
Hospira;
Ono Pharmaceuticals

None

None

12/16/2014

Peter Curtin, MD

Celgene

None

None

None

11/24/2014

Mary Dwyer, MS

None

None

None

None

10/9/2014

Thomas Fynan, MD

Yale University

None

None

None

12/9/2014

Lauren Gallagher, RPh, PhD

None

None

None

None

12/8/2014

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

9/16/2014

Elizabeth A. Griffiths, MD

Astex Pharmaceuticals

Alexion Pharmaceuticals, Inc.;
Alexion Pharmaceuticals, Inc.;
ARIAD Pharmaceuticals, Inc.;
Celgene Corporation;
Novartis Pharmaceuticals Corporation;
Astex Pharmaceuticals;
Incyte

None

None

11/21/2014

Shannon M. Hough, PharmD, BCOP

None

None

None

None

10/15/2014

Dwight D. Kloth, PharmD, FCCP, BCOP

None

Amgen Inc.;
Eisai Inc.;
Teva Oncology

None

None

9/10/2014

David J. Kuter, MD, PhD

None

Amgen Inc.;
3SBIO;
caremark;
CRICO;
Kirin

None

None

10/15/2014

Gary H. Lyman, MD, MPH, FRCP

Amgen Inc.

None

None

None

10/28/2014

Joan S. McClure, MS

None

None

None

None

12/8/2014

Brandon McMahon, MD

None

Bristol-Myers Squibb Company;
Pfizer Inc.

None

None

12/17/2014

Eric Padron, MD

Incyte

Incyte;
KaloBios;
Novarits

None

None

11/3/2014

Jacqueline Parpal, PharmD

None

None

None

None

8/12/2014

Raajit Rampal, MD, PhD

None

Incyte Corportation

None

None

11/24/2014

Vivek Roy, MD

None

None

None

None

9/18/2014

Hope S. Rugo, MD

None

Genomic Health, Inc.

None

None

8/28/2014

Ayman A. Saad, MD

None

IMS Consulting Group

None

ICARE

12/18/2014

Lee S. Schwartzberg, MD, FACP

Bristol-Myers Squibb Company;
Eisai Inc.

Amgen Inc.;
Amgen Inc.;
Bristol-Myers Squibb Company;
Eisai Inc.;
Genentech, Inc.;
Genentech, Inc.;
GlaxoSmithKline;
GlaxoSmithKline

None

None

7/14/2014

Sepideh Shayani, PharmD, BCOP

None

Spectrum

None

ICONN

11/26/2014

Courtney Smith, PhD

None

None

Johnson & Johnson;
OPKO

None

11/7/2014

Mahsa Talbott, PharmD

None

None

None

None

8/26/2014

Sarika Trikha, PharmD

None

None

None

None

11/11/2014

Saroj Vadhan-Raj, MD

Amgen Inc.

Amgen Inc.;
Jannsen Pharmaceutica Products, LP

None

None

11/6/2014

Martha Wadleigh, MD

None

None

None

None

9/9/2014

Peter Westervelt, MD, PhD

Celgene Corporation

None

None

None

12/9/2014

Michael Westmoreland, PharmD

None

Merck & Co., Inc.;
Merck & Co., Inc.;
Astellas

None

None

10/23/2014